Fennec Pharmaceuticals, Inc. (FENC)
11.74
+0.34
(+2.98%)
USD |
NASDAQ |
Aug 25, 16:00
11.74
0.00 (0.00%)
After-Hours: 18:41
Fennec Pharmaceuticals Market Cap : 411.30M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 399.39M |
| August 21, 2026 | 395.53M |
| August 20, 2026 | 397.64M |
| August 19, 2026 | 415.85M |
| August 18, 2026 | 415.85M |
| August 17, 2026 | 414.45M |
| August 14, 2026 | 410.60M |
| August 13, 2026 | 422.51M |
| August 12, 2026 | 414.45M |
| August 11, 2026 | 447.73M |
| August 10, 2026 | 383.27M |
| August 07, 2026 | 405.52M |
| August 06, 2026 | 379.77M |
| August 05, 2026 | 363.37M |
| August 04, 2026 | 349.21M |
| August 03, 2026 | 331.25M |
| July 31, 2026 | 330.56M |
| July 30, 2026 | 342.30M |
| July 29, 2026 | 333.32M |
| July 28, 2026 | 343.34M |
| July 27, 2026 | 352.66M |
| July 24, 2026 | 345.06M |
| July 23, 2026 | 350.59M |
| July 22, 2026 | 356.46M |
| July 21, 2026 | 358.88M |
| Date | Value |
|---|---|
| July 20, 2026 | 341.96M |
| July 17, 2026 | 362.68M |
| July 16, 2026 | 360.61M |
| July 15, 2026 | 366.13M |
| July 14, 2026 | 385.48M |
| July 13, 2026 | 371.32M |
| July 10, 2026 | 362.34M |
| July 09, 2026 | 356.12M |
| July 08, 2026 | 354.05M |
| July 07, 2026 | 362.68M |
| July 06, 2026 | 369.24M |
| July 02, 2026 | 369.59M |
| July 01, 2026 | 357.15M |
| June 30, 2026 | 371.32M |
| June 29, 2026 | 380.99M |
| June 26, 2026 | 380.64M |
| June 25, 2026 | 364.41M |
| June 24, 2026 | 359.23M |
| June 23, 2026 | 355.77M |
| June 22, 2026 | 329.18M |
| June 18, 2026 | 312.94M |
| June 17, 2026 | 310.18M |
| June 16, 2026 | 309.49M |
| June 15, 2026 | 317.43M |
| June 12, 2026 | 310.87M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abeona Therapeutics, Inc. | 355.66M |
| ACADIA Pharmaceuticals, Inc. | 5.264B |
| Alnylam Pharmaceuticals, Inc. | 32.09B |
| Anika Therapeutics, Inc. | 288.00M |
| Savara, Inc. | 1.148B |
Market Cap Related Metrics
| PS Ratio | 6.494 |
| Price to Book Value | 9.691 |
| Price | 11.74 |
| Earnings Yield | -1.09% |